Reply to McShane

Author:

Hill Philip C1ORCID,Cobelens Frank23,Martinez Leonardo4,Garcia-Basteiro Alberto L567,Behr Marcel A8,Rangaka Molebogeng X91011,Churchyard Gavin121314,Evans Tom15,Hanekom Willem1617,White Richard G18ORCID

Affiliation:

1. Centre for International Health, University of Otago , Dunedin , New Zealand

2. Department of Global Health, Amsterdam University Medical Centre , Amsterdam , The Netherlands

3. Amsterdam Institute for Global Health and Development, Amsterdam University Medical Centre , Amsterdam , The Netherlands

4. Department of Epidemiology, School of Public Health, Boston University , Boston, Massachusetts , USA

5. Centro de Investigação em Saúde de Manhiça , Maputo , Mozambique

6. Instituto de Salud Global, Hospital Clínic-Universitat de Barcelona , Barcelona , Spain

7. Centro de Investigación Biomédica en Red de Enfermedades Infecciosas , Barcelona , Spain

8. McGill International TB Centre, McGill University , Montreal, Quebec , Canada

9. Institute for Global Health, University College London , London , United Kingdom

10. MRC Clinical Trials Unit, University College London , London , United Kingdom

11. Centre for Infectious Diseases Research Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town , Cape Town , South Africa

12. The Aurum Institute , Parktown , South Africa

13. Department of Medicine, Vanderbilt University , Nashville, Tennessee , USA

14. School of Public Health, University of the Witwatersrand , Johannesburg , South Africa

15. Vaccitech , Oxford , United Kingdom

16. Africa Health Research Institute , Durban, KwaZulu-Natal , South Africa

17. Division of Infection and Immunity, University College London , London , United Kingdom

18. Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine , London , United Kingdom

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Reference3 articles.

1. An aspiration to radically shorten phase 3 tuberculosis vaccine trials;Hill;J Infect Dis

2. Improving TB vaccine trial efficiency: a tough nut to crack;McShane;J Infect Dis

3. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults;Lal;N Engl J Med,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3